CTOs on the Move

Recovree

www.recovree.com

 
We help people find and maintain recovery from substance misuse through peer relationships. Recovree provides services to support the health and wellness of employees including on-demand access to recovery coaches with lived-experience, comprehensive chemical health assessments, and incident response planning. Employees struggling with drug and alcohol addiction can have a significant impact on a company`s productivity, safety and culture. Our services help employers retain top talent, improve the health and wellness of their teams and provide better access to resources for people who need help now. Check out our Recovery Friendly Workplace Toolkit, where we introduce you to the disease ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.recovree.com
  • 370 Wabasha Street N. Suite 500
    Staint Paul, MN USA 55102
  • Phone: 651.419.1719

Executives

Name Title Contact Details
Mike Milkovich
 Chief Technology Officer Profile

Similar Companies

Mahaska Health Partnership

Mahaska Health Partnership is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Oskaloosa, IA. To find more information about Mahaska Health Partnership, please visit www.mahaskahealth.org

EHE Health

EHE is America`s leading prevention company. We work with major clients from diverse fields to help their employees reach optimal health through comprehensive exams and year-round mentoring and resources. Our holistic, personalized approach improves longevity, productivity, and performance. For more than 100 years, EHE has led the way in preventive health care. We continue to grow and innovate, providing individuals with what they need to feel their best every day.

Renaissance Resource Associate

Renaissance Resource Associate is a Tacoma, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Symbiomix Therapeutics

Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women`s health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world`s leading healthcare venture capital firms, OrbiMed, Fidelity Biosciences and HBM Partners. The Company`s lead product is SYM-1219, a novel drug candidate containing secnidazole, which is a next generation 5-nitroimidazole antibiotic. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.

FibroGen

FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs. FibroGen’s research team is committed to discovering novel therapies in areas of major unmet medical need. Our goal is to continue to provide pipeline candidates supported by rigorous data in well-characterized therapeutic settings. All of FibroGen`s therapeutic candidates have been internally developed based on FibroGen`s pioneering research in two important areas of biology, hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF).